Cadrenal Therapeutics

(NASDAQ) CVKD

Current Price$6.59

Market Cap$16.72M

Since IPO (2023)-91%

5 YearN/A

1 Year-67%

1 Month+32%

Cadrenal Therapeutics Financials at a Glance

Market Cap

$16.72M

Revenue (TTM)

$0.00

Net Income (TTM)

$13.24M

EPS (TTM)

$-6.68

P/E Ratio

-1.00

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$6.59

Volume

1,780

Open

$5.98

Price

$6.59

Volume

1,780

Open

$5.98

Previous Close

$6.59

Daily Range

$5.98 - $6.72

52-Week Range

$4.21 - $17.00

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$6.59

Volume

1,780

Open

$5.98

Previous Close

$6.59

Daily Range

$5.98 - $6.72

52-Week Range

$4.21 - $17.00

CVKD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cadrenal Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Quang X. Pham

Website

www.cadrenal.com

Headquarters

Ponte Vedra, FL 32082, US

CVKD Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-260%

Return on Capital

-5%

Return on Assets

-3%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.72M

Shares Outstanding

2.51M

Volume

1.78K

Avg. Volume

50.92K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$13.46M

EBITDA

$13.46M

Operating Cash Flow

$12.60M

Capital Expenditure

$5.10K

Free Cash Flow

$12.60M

Cash & ST Invst.

$4.01M

Total Debt

$0.00

Cadrenal Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$555.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$16.72M

N/A

Market Cap/Employee

$4.18M

N/A

Employees

N/A

Net Income

$3.04M

+27.4%

EBITDA

$3.07M

+26.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.01M

-60.0%

Accounts Receivable

$5.10K

-86.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-3.06%

N/A

Return on Invested Capital

-4.92%

N/A

Free Cash Flow

$2.57M

-43.2%

Operating Cash Flow

$2.57M

-43.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TAOXTAO Synergies Inc.

TAOXTAO Synergies Inc.$5.13+6.21%

NRSNNeuroSense Therapeutics Ltd.

NRSNNeuroSense Therapeutics Ltd.$0.82+2.23%

XCURExicure, Inc.

XCURExicure, Inc.$3.36+1.51%

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.69+4.32%

CLGNCollPlant Biotechnologies Ltd.

CLGNCollPlant Biotechnologies Ltd.$0.38+2.77%

ITRMIterum Therapeutics plc

ITRMIterum Therapeutics plc$0.03-10.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

FFord Motor Company

FFord Motor Company$12.08-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.47+0.05%

Questions About CVKD

What is the current price of Cadrenal Therapeutics?

Cadrenal Therapeutics is trading at $6.59 per share.

What is the 52-week range for Cadrenal Therapeutics?

Over the past 52 weeks, Cadrenal Therapeutics has traded between $4.21 and $17.00.

How much debt does Cadrenal Therapeutics have?

As of the most recent reporting period, Cadrenal Therapeutics reported total debt of N/A.

How much cash does Cadrenal Therapeutics have on hand?

Cadrenal Therapeutics reported $4.01M in cash and cash equivalents in its most recent financial results.

What is Cadrenal Therapeutics’s dividend yield?

Cadrenal Therapeutics does not currently have a dividend yield.

Cadrenal Therapeutics

Cadrenal Therapeutics Financials at a Glance

CVKD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cadrenal Therapeutics

CVKD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cadrenal Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CVKD

What is the current price of Cadrenal Therapeutics?

What is the 52-week range for Cadrenal Therapeutics?

How much debt does Cadrenal Therapeutics have?

How much cash does Cadrenal Therapeutics have on hand?

What is Cadrenal Therapeutics’s dividend yield?

Premium Investing Services